Target expression details
Target's General Information | |||||
---|---|---|---|---|---|
Target ID | T42928 | ||||
Target Name | Fibroblast growth factor-21 (FGF21) | ||||
Synonyms | UNQ3115/PRO10196; Fibroblast growth factor 21; FGF-21 | ||||
Target Type | Clinical trial | ||||
Gene Name | FGF21 | ||||
Biochemical Class | Growth factor | ||||
UniProt ID | FGF21_HUMAN | ||||
Target's Expression Profile in Disease Related Tissue between Patients and Normal People | |||||
Disease | Type 2 diabetes | ||||
Example drug | PF-05231023 | Phase 1 | [1], [2], [3] | ||
Tissue | Liver tissue | ||||
Level of differential expression between the patients in the disease section of the tissue and the tissues of healthy individual |
Fold-change: 0.05 Z-score: 0.22 P-value: 9.68E-01 |
||||
Target gene expression profiles of the patients in the disease section of the tissue
Target gene expression profiles in the tissue of healthy individual
|
|||||
Target's Expression Profile across Various Tissues of Healthy Individual | |||||
References | |||||
REF 1 | ClinicalTrials.gov (NCT01923389) Multiple Dose Study Of PF-05231023 In Obese Adult Subjects. U.S. National Institutes of Health. | ||||
REF 2 | Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41. | ||||
REF 3 | NCBI GEO: archive for functional genomics data sets--update. Nucleic Acids Res. 2013 Jan;41(Database issue):D991-5. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.